ArticleAsian journal of pharmaceutical sciences2022

Elaborately engineering of a dual-drug co-assembled nanomedicine for boosting immunogenic cell death and enhancing triple negative breast cancer treatment.

Chen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.